Has been used orally (in combination with other antiemetic agents) for prevention of acute and delayed nausea and vomiting associated with highly emetogenic cancer chemotherapy† [off-label], including high-dose cisplatin therapy.For prevention of nausea and vomiting associated with highly emetogenic...
2.7 Olanzapine and Fluoxetine in Combination: Dosing in Special Populations The starting dose of oral olanzapine 2.5 to 5 mg with fluoxetine 20 mg should be used for patients with a predisposition to hypotensive reactions, patients with hepatic impairment, or patients who exhibit a combination of fa...
It is suggested that after proper clinical evaluation, the dosage should be increased to the normal dose of 10mg/ day, and the interval of dosing should not be less than 24 hours. The dosage should be gradually reduced when the nitrogen is stopped. Manic episode: The initial dose of ...
Nausea, vomiting, or diarrhea Muscle twitching, stiffness, or tremor Seizures Severe Allergic Reactions. Olanzapine/fluoxetine may cause allergic reactions, including a specific type of allergic reaction called DRESS. DRESS stands for Drug Reaction with Eosinophilia and Systemic Symptoms. It is also some...
Intramuscular Dosing In Special Populations A dose of 5 mg/injection should be considered for geriatric patients or when other clinical factors warrant.A lower dose of 2.5 mg/injection should be considered for patients who otherwise might be debilitated, be predisposed to hypotensive reactions, or ...
It is suggested that the drugs exceeding the recommended dose can be used only after appropriate clinical re evaluation, and the interval of dosing should not be less than 24 hours. Olanzapine does not need to consider the factors of eating, and the food does not affect ...
Table 1: Recommended Dosing for ZYPREXA RELPREVV Based on Correspondence to Oral ZYPREXA Doses ZYPREXA RELPREVV doses greater than 405 mg every 4 weeks or 300 mg every 2 weeks have not been evaluated in clinical trials. Post-Injection Delirium/Sedation Syndrome ...
申办方 (SC) The Hospital For Sick Children 合作方 (SC) Children'S Mercy Hospital Kansas City | 哥伦比亚大学 | 南卡罗来纳医科大学 | Nationwide Children'S Hospital | Cancercare Manitoba 试验详情 试验目的 Chemotherapy-induced nausea and vomiting (CINV) are among the most bothersome symptoms during...
Olanzapine is effective in the treatment of overall and delayed chemotherapy-induced nausea and vomiting based on meta-analysis of RCTs [90,91]. Data for chronic nausea and emesis associated with gastroparesis is lacking. It is reasonable to use olanzapine for patients with nausea and emesis ...
BackgroundThis retrospective review provides preliminary data regarding the safety and efficacy of olanzapine for chemotherapy-induced vomiting (CIV) control in children.ProcedureChildren <18 years old who received olanzapine for acute chemotherapy-induced nausea and vomiting (CINV) control from December ...